Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence

Summary

The aromatase inhibitor (anastrazole) plus long acting GnRH agonist leuprolide acetate will be tested for the treatment of women with endometriosis recurrence compared with classical GnRH analog treatment. Pain symptom disappearance and disease free time during follow-up will be the outcomes for establishing which medical treatment is the best in endometriosis recurrence treatment.

Timeline

Start

2013-01

Primary completion

2015-07

Completion

2015-07

Drugs

Indications